Table 1

Association of 14-3-3σ expression with patient's characteristics in primary gastric cancer

Variable

All cases

Training set (n = 66)

Testing set (n = 86)


High

expression

Low

expression

p a

High

expression

Low

expression

p a


Age (years)

≥ 58.00 b

83

25(30.1%)

13(15.7%)

0.627

29(34.9%)

16(19.3%)

0.010

< 58.00

69

20(29.0%)

8(11.6%)

15(21.7%)

26(37.7%)

Gender

Male

105

29(27.6%)

16(15.2%)

0.340

31(29.5%)

29(27.6%)

0.887

Female

47

16(34.0%)

5(10.6%)

13(27.7%)

13(27.7%)

Clinical stage

I + II

45

6(13.3%)

12(26.7%)

0.000

6(13.3%)

21(46.7%)

0.000

III + IV

107

39(36.4%)

9(8.4%)

38(35.5%)

21(19.6%)

Tumor invasion

T1+T2

23

0(0%)

7(30.4%)

0.000

3(13.0%)

13(56.5%)

0.005

T3+T4

129

45(34.9%)

14(10.9%)

41(31.8%)

29(22.5%)

Node stage

N0+N1

101

32(31.7%)

15(14.9%)

0.979

24(23.8%)

30(29.7%)

0.105

N2+N3

51

13(25.5%)

6(11.8%)

20(39.2%)

12(23.5%)

Histology-differentiation

Well

51

15(29.4%)

11(21.6%)

0.123

11(21.6%)

14(27.5%)

0.395

Poorly

101

31(30.7%)

10(9.9%)

33(32.7%)

28(27.7%)


a x2 test

b median age

Zhou et al. BMC Cancer 2011 11:397   doi:10.1186/1471-2407-11-397

Open Data